Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study.

MLA

Yan, Chong, et al. “Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study.” Neurology & Therapy, vol. 11, no. 2, June 2022, pp. 815–34. EBSCOhost, https://doi.org/10.1007/s40120-022-00345-9.

APA

Yan, C., Duan, R.-S., Yang, H., Li, H.-F., Zou, Z., Zhang, H., Zhou, H., Li, X.-L., Zhou, H., Jiao, L., Chen, J., Yin, J., Du, Q., Lee, M., Chen, Y., Chen, X., & Zhao, C. (2022). Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study. Neurology & Therapy, 11(2), 815–834. https://doi.org/10.1007/s40120-022-00345-9

Chicago

Yan, Chong, Rui-Sheng Duan, Huan Yang, Hai-Feng Li, Zhangyu Zou, Hua Zhang, Hongyu Zhou, et al. 2022. “Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study.” Neurology & Therapy 11 (2): 815–34. doi:10.1007/s40120-022-00345-9.